Detailed Abstract
[Poster Presentation]
[BP PP 4-3] Oncologic outcome and the optimal time of sequential EC in incidentally found T2 GB cancer
Moon Young OH, Hongbeom KIM*, Jae-Seung KANG, Heeju SON, Youngmin HAN, Wooil KWON, Jin-Young JANG
Department of Surgery and Cancer Research Institute, Seoul National University, Korea
Introduction : Sequential extended cholecystectomy (SEC) is currently recommended for gallbladder cancer (GBC) stage T2 and higher incidentally found after simple cholecystectomy, but the value, timing and extent of re-resection has not been fully studied. This study evaluated long-term oncologic outcomes according to the type of surgery and time interval from initial cholecystectomy to SEC.
Methods : Patients diagnosed with T2 GBC who underwent extended cholecystectomy (EC), SEC or simple cholecystectomy (SC) between 2002 and 2017 were retrospectively reviewed.
Results : In 226 patients diagnosed with T2 GBC, 173, 44, and 53 patients underwent EC, SEC, and SC, respectively. Age, ASA performance score was higher in the SC group than EC and SEC groups combined. Five-year overall survival (OS) was 73.2%, 78.7% and 50.1%, and disease-free survival (DFS) was 66.3%, 65.2% and 46.8% for EC, SEC, and SC patients, respectively. OS and DFS were higher in EC than SC (p=0.007 and p=0.001), higher in SEC than SC (p=0.001 and p=0.065), but similar between EC and SEC (p=0.909 and p=0.722). SEC patients who underwent SEC ≤30days after initial cholecystectomy had longer DFS than the >30days group (114 months vs 71 months, p=0.023). Recurrence pattern (local or distant) of SC vs EC and SEC combined showed significant difference, but not between EC and SEC. Seventeen of 18 SC recur patients had distant metastasis at the time of recurrence.
Conclusions : SEC is recommended for incidental T2 GBC because SEC provides better survival outcomes than SC alone. A time interval of ≤30days between initial cholecystectomy and SEC is recommended.
Methods : Patients diagnosed with T2 GBC who underwent extended cholecystectomy (EC), SEC or simple cholecystectomy (SC) between 2002 and 2017 were retrospectively reviewed.
Results : In 226 patients diagnosed with T2 GBC, 173, 44, and 53 patients underwent EC, SEC, and SC, respectively. Age, ASA performance score was higher in the SC group than EC and SEC groups combined. Five-year overall survival (OS) was 73.2%, 78.7% and 50.1%, and disease-free survival (DFS) was 66.3%, 65.2% and 46.8% for EC, SEC, and SC patients, respectively. OS and DFS were higher in EC than SC (p=0.007 and p=0.001), higher in SEC than SC (p=0.001 and p=0.065), but similar between EC and SEC (p=0.909 and p=0.722). SEC patients who underwent SEC ≤30days after initial cholecystectomy had longer DFS than the >30days group (114 months vs 71 months, p=0.023). Recurrence pattern (local or distant) of SC vs EC and SEC combined showed significant difference, but not between EC and SEC. Seventeen of 18 SC recur patients had distant metastasis at the time of recurrence.
Conclusions : SEC is recommended for incidental T2 GBC because SEC provides better survival outcomes than SC alone. A time interval of ≤30days between initial cholecystectomy and SEC is recommended.
SESSION
Poster Presentation
E-Session 3/25 ~ 3/27 ALL DAY